45 related articles for article (PubMed ID: 18384511)
1. Availability of a microglia and macrophage marker, iba-1, for differential diagnosis of spontaneous malignant reticuloses from astrocytomas in rats.
Nakamura R; Nishimura T; Ochiai T; Nakada S; Nagatani M; Ogasawara H
J Toxicol Pathol; 2013 Mar; 26(1):55-60. PubMed ID: 23723569
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury.
Lalancette-Hébert M; Swarup V; Beaulieu JM; Bohacek I; Abdelhamid E; Weng YC; Sato S; Kriz J
J Neurosci; 2012 Jul; 32(30):10383-95. PubMed ID: 22836271
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Cancer Detection, Diagnosis, and Prognosis.
Das S; Dey MK; Devireddy R; Gartia MR
Sensors (Basel); 2023 Dec; 24(1):. PubMed ID: 38202898
[TBL] [Abstract][Full Text] [Related]
4. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
[TBL] [Abstract][Full Text] [Related]
5. Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy?
Luís C; Soares R; Baylina P; Fernandes R
Front Endocrinol (Lausanne); 2022; 13():805837. PubMed ID: 35321333
[TBL] [Abstract][Full Text] [Related]
6. Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.
He X; Zhang S; Chen J; Li D
Cancer Med; 2019 May; 8(5):2031-2040. PubMed ID: 30848102
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.
Cymbaluk-Płoska A; Chudecka-Głaz A; Jagodzińska A; Pius-Sadowska E; Sompolska-Rzechuła A; Machaliński B; Menkiszak J
Onco Targets Ther; 2018; 11():1363-1372. PubMed ID: 29559794
[TBL] [Abstract][Full Text] [Related]
8. The role of galectin-3 in the tumorigenesis and progression of pituitary tumors.
Diao B; Liu Y; Xu GZ; Zhang Y; Xie J; Gong J
Oncol Lett; 2018 Apr; 15(4):4919-4925. PubMed ID: 29545898
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 and cancer stemness.
Nangia-Makker P; Hogan V; Raz A
Glycobiology; 2018 Apr; 28(4):172-181. PubMed ID: 29315388
[TBL] [Abstract][Full Text] [Related]
10. Galectins as cancer biomarkers.
Balan V; Nangia-Makker P; Raz A
Cancers (Basel); 2010 Apr; 2(2):592-610. PubMed ID: 23658855
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.
Ha SY; Kang SY; Do IG; Suh YL
J Neurooncol; 2013 May; 112(3):439-48. PubMed ID: 23412777
[TBL] [Abstract][Full Text] [Related]
12. Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling.
Gensel JC; Kigerl KA; Mandrekar-Colucci SS; Gaudet AD; Popovich PG
Cell Tissue Res; 2012 Jul; 349(1):201-13. PubMed ID: 22592625
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC.
Wu F; Hu N; Li Y; Bian B; Xu G; Zheng Y
Cell Oncol (Dordr); 2012 Jun; 35(3):175-80. PubMed ID: 22476961
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children.
Borges CB; Bernardes ES; Latorraca EF; Becker AP; Neder L; Chammas R; Roque-Barreira MC; Machado HR; de Oliveira RS
Childs Nerv Syst; 2011 Feb; 27(2):253-7. PubMed ID: 20711594
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.
Zhou JY; Afjehi-Sadat L; Asress S; Duong DM; Cudkowicz M; Glass JD; Peng J
J Proteome Res; 2010 Oct; 9(10):5133-41. PubMed ID: 20698585
[TBL] [Abstract][Full Text] [Related]
16. In pursuit of prognostic factors in children with pilocytic astrocytomas.
Paixão Becker A; de Oliveira RS; Saggioro FP; Neder L; Chimelli LM; Machado HR
Childs Nerv Syst; 2010 Jan; 26(1):19-28. PubMed ID: 19823847
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3: a useful biomarker for differential diagnosis of brain tumors.
Park SH; Min HS; Kim B; Myung J; Paek SH
Neuropathology; 2008 Oct; 28(5):497-506. PubMed ID: 18384511
[TBL] [Abstract][Full Text] [Related]
18. Secretagogin expression in tumours of the human brain and its coverings.
Pipp I; Wagner L; Rössler K; Budka H; Preusser M
APMIS; 2007 Apr; 115(4):319-26. PubMed ID: 17504298
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study.
Rodriguez FJ; Scheithauer BW; Roncaroli F; Silva AI; Kovacs K; Brat DJ; Jin L
Am J Surg Pathol; 2008 Sep; 32(9):1344-52. PubMed ID: 18670355
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
